Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction

Internal Medicine

Volumn 43, Issue 4, 2004, Pages 289-294

  Fujikawa, Keita ^a   Ohata, Kazuyuki ^a   Honda, Takuya ^a   Miyazoe, Seiji ^a   Ichikawa, Tatsuki ^a   Ishikawa, Hiroki ^a   Hamasaki, Keisuke ^a   Nakao, Kazuhiko ^a   Toriyama, Kan ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Hepatic fibrosis; Nonalcoholic steatohepatitis; Weight reduction

Indexed keywords

LIPID; NEOMINOPHAGEN C;

AGED; ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNITY; BIOCHEMISTRY; CASE REPORT; CLINICAL EXAMINATION; DIET THERAPY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; KINESIOTHERAPY; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; NONALCOHOLIC FATTY LIVER; OBESITY; TREATMENT OUTCOME; WEIGHT REDUCTION;

AGED; BIOPSY; EXERCISE THERAPY; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; LIVER; LIVER CIRRHOSIS; WEIGHT LOSS;

EID: 2542425712     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.289     Document Type: Article

References (25)

1. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 126: 137-145, 1997.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219, 2003.
3. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 121: 710-723, 2001.
4. Ludwig J, Viggiano T, McGill D, Oh BJ. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438, 1980.
5. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362, 1999.
6. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109, 1994.
7. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20: 594-598, 1989.
8. Powell E, Cooksley W, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74-80, 1990.
9. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27: 103-107, 1997.
10. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42: 1428-1432, 1997.
11. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 125: 239-241, 1994.
12. Saksena S, Johnson J, Ouiff SP, Elias E. Diet and exercise: important first steps in therapy of NASH. Hepatology 30: 436A, 1999.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model of assessment: insulin resistance and β-cell function arising from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
14. Kato H, Nakata K, Hamasaki K, et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 18: 581-587, 2000.
15. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
16. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474, 1999.
17. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140, 2002.
18. Shimada M, Hashimoto E, Taniai M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 37: 154-160, 2002.
19. Garcia-Monzon C, Martin-Perez E, Iacono OL, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33: 716-724, 2000.
20. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12: 224-229, 1991.
21. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6: 998-1003, 2000.
22. Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol 31: 384, 1999.
23. Guma C, Viola L, Thome M, Galdame O, Alvarez E. Ursodeoxycholic acid in the treatment of nonalcoholic steatohepatitis: results of a prospective clinical controlled trial. Hepatology 26: 387A, 1997.
24. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 136: 734-738, 2000.
25. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 358: 893-894, 2001.